Immunomatics Raises $100,000 in Funding

Immunomatics, based in San Marcos, California, is a healthtech company developing AI-driven tools to enhance transplant donor-recipient risk assessment. The company has secured $100,000 in a strategic investment round.

Investors

Myosotis Investments B.V., a life sciences investment firm founded by entrepreneur Wietse Mulder, provided the funding.

Immunomatics Use of Funds

The company intends to use the capital to accelerate the validation and commercialization of its AI-based donor risk assessment technology, as well as to expand its clinical data and advance its regulatory strategy.

About Immunomatics

Founded by Lidio Meireles, Immunomatics is a healthtech startup focused on improving transplant outcomes. The company utilizes machine learning, HLA typing, and outcomes data to provide clinical decision support tools for blood stem cell and solid organ transplantation.

Funding Details

Company Website: https://immunomatics.com

Company: Immunomatics
Raised: $100,000
Round: Strategic Investment
Funding Date: October 7, 2026
Additional Investors: Myosotis Investments B.V.
Software Category: Healthtech
Source: https://www.prnewswire.com/news-releases/gendx-co-founder-wietse-mulder-invests-100-000-in-ai-transplant-company-immunomatics-and-joins-as-strategic-advisor-302900371.html